Sign In
Buy DYAI
$1.05
-0.0200 (-1.87%)
At Close: Jul 31, 2026
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
08:30am, Tuesday, 13'th Feb 2024
JUPITER, Fla. and LELAND, N.C., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences�
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
08:30am, Tuesday, 06'th Feb 2024
JUPITER, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company announce
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
08:30am, Thursday, 01'st Feb 2024
JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial
Dyadic International, Inc Invites You to Join Us at The Microcap Conference
08:00am, Monday, 22'nd Jan 2024
Jupiter, Florida--(Newsfile Corp. - January 22, 2024) - Dyadic International, Inc (NASDAQ: DYAI), Dyadic International, Inc. is a global biotechnology company focused on building innovative microbial
Dyadic International, Inc. (DYAI) Q3 2023 Earnings Call Transcript
11:23pm, Wednesday, 08'th Nov 2023
Dyadic International, Inc. (NASDAQ:DYAI ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Mark Emalfarb - President, Chief Executive Officer Ping Rawson - Chief Finan
Dyadic to Present at Industry Events in November
08:30am, Monday, 30'th Oct 2023
JUPITER, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
04:30pm, Wednesday, 25'th Oct 2023
JUPITER, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused o
Dyadic to Present at Industry and Investor Events in October
08:30am, Friday, 29'th Sep 2023
JUPITER, Fla., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbia
Dyadic to Present at BioProcess International
04:30pm, Tuesday, 12'th Sep 2023
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbia
Dyadic International, Inc. (DYAI) Q2 2023 Earnings Call Transcript
11:41pm, Wednesday, 09'th Aug 2023
Dyadic International, Inc. (NASDAQ:DYAI ) Q2 2023 Earnings Conference Call August 9, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financial Officer Mark Emalfarb - President and Chief Exec
Dyadic to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
04:30pm, Wednesday, 26'th Jul 2023
JUPITER, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused o
Dyadic International, Inc. (DYAI) Q1 2023 Earnings Call Transcript
10:19pm, Wednesday, 10'th May 2023
Dyadic International, Inc. (NASDAQ:DYAI ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Ping Rawson - Chief Financial Officer Mark Emalfarb - President and Chief Execut
Dyadic to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023
04:30pm, Wednesday, 26'th Apr 2023
JUPITER, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused
Dyadic reports 21.9% revenue rise, $12.7M in cash for full year 2022 as it rapidly advances technology
09:51am, Thursday, 30'th Mar 2023
Dyadic International Inc (NASDAQ:DYAI) posted its financial results for the year ended 2022 with revenue surging 21.9% year-over-year on the back of license agreements as it rapidly advanced its tech
Dyadic to Present at World Vaccine Congress Washington 2023
08:30am, Thursday, 30'th Mar 2023
JUPITER, Fla., March 30, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbia
